IL10 and osteosarcoma: To investigate, in vivo, the efficacy of counteracting OS metastatic dissemination by administration of the anti-IL-10 antibody combined with mifamurtide, we performed a lung retention assay in BALB/c mice injected with the highly metastatic K7M2 osteosarcoma murine cells (Figure 6A).